从血液恶性瘤到与衰老相关的疾病的CAR T疗法:一个不断扩大的宇宙
Davide Ramoni1, Fabrizio Montecucco1,2, Federico Carbone1,2
1Department of Internal Medicine, University of Genoa, Genoa, Italy.
European journal of clinical investigation
|March 29, 2024
概括
化学抗原受体T (CAR T) 疗法通过清除衰老细胞,对抗衰老和代谢疾病具有前景. 然而,输注前化疗的风险限制了其在非癌症条件下使用.
科学领域:
- 免疫治疗是一种免疫疗法.
- 基因编辑 基因编辑
- 细胞生物学 细胞生物学
背景情况:
- 基因编辑在过去二十年里彻底改变了血液癌症的治疗方法.
- 化学抗原受体T (CAR T) 疗法是一种基因编辑进步,尚未在固体瘤或非瘤性疾病中取得类似的成功.
研究的目的:
- 审查CAR T疗法的挑战和潜在应用,不仅仅是血液性恶性瘤.
- 探索CAR T的老化潜力及其对衰老和代谢疾病的影响.
- 确定阻碍CAR T疗法的扩展到非瘤应用的关键局限性.
主要方法:
- 这篇叙事综述综合了关于CAR T疗法的当前研究.
- 它检查了固体瘤微环境所带来的障碍.
- 它讨论了关于长期活动和非瘤环境中的不可预测后果的担忧.
主要成果:
- 卡尔-T疗法显示出老化潜力,清除衰老细胞以改善衰老中的运动能力和代谢功能.
- 输注前的淋巴损伤化疗是CAR T扩张所必需的,具有基因毒性风险.
- 这些风险是应用CAR T在非恶性疾病中的重要障碍.
结论:
- 工程NK细胞和巨细胞为改善CART在固体瘤和非瘤疾病中的应用提供了潜力.
- 需要对替代CAR细胞类型进行进一步的研究.
- 人们对来自老年人的CAR T细胞的功能和细胞因子释放存在担忧.
相关概念视频
01:21Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
01:27Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
01:22Bone Marrow Sampling and Transplants
328
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
328
01:19Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K